封面
市場調查報告書
商品編碼
1438479

穿戴式機器人和外骨骼:市場佔有率分析、行業趨勢和統計、成長預測(2024-2029)

Wearable Robots and Exoskeletons - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

穿戴式機器人和外骨骼市場規模預計到 2024 年為 25.5 億美元,在預測期內(2024-2029 年)預計到 2029 年將達到 102.5 億美元,年複合成長率為 32.05%。

穿戴式機器人和外骨骼 - 市場

由於Covid-19感染疾病的出現以及迄今為止各地實施的封鎖措施,機器人供應商在短時間內陷入完全停滯。然而,另一方面,疫情對產品和服務提供者提出了挑戰,要求他們透過與臨床醫生和行業合作夥伴合作、應對不斷變化的衛生服務並主要關注現實世界的臨床挑戰來行銷其產品和服務。存在增加的行業機會。患者的需求。

主要亮點

  • 穿戴式機器人或外骨骼正處於發展的早期階段,這些穿戴式外骨骼輔助個體運動,可以附著在人體上並由人體控制,使其在醫療保健、工業、軍事、它不斷發展以代表最新的採用。它也有助於人們的運動。
  • 在醫療保健領域,外骨骼透過協助和促進直立行走和重新學習失去的功能來幫助中風患者和癱瘓患者康復。根據 Maxon Motor AG 的研究,該公司估計全球約有 1.85 億人每天使用輪椅。
  • 例如,Ekso GT是Esko Bionics公司的一款外骨骼,是一款穿戴式外骨骼,設計為綜合步態治療工具,為患者和治療師提供無與倫比的復健體驗。此外,科技的進步使得法國一名癱瘓男子開始使用意念控制外骨骼行走。
  • 業內多家公司已經測試了他們的外骨骼製造能力並準備部署它們,未來市場可能會進一步擴大。例如,汽車製造商福特選擇了 EksoVest,計劃在全球 15 個組裝廠部署外骨骼。這種外骨骼可以舉起並支撐執行重複性頭頂任務的工人的手臂。 EksoVest 在試用期間將職場減少了 83%。
  • 對幫助個人移動的外骨骼的需求也在增加。患有帕金森氏症和中風等身體運動障礙的患者數量不斷增加,是加速外骨骼需求的主要因素。這是因為這些疾病限制了自主身體運動並導致日常生活活動出現問題。例如,帕金森氏症基金會估計,2020年美國帕金森氏症患者人數可能約93萬人,預計2030年將達到120萬人。

穿戴式機器人和外骨骼市場趨勢

醫療保健預計將佔據很大佔有率

  • 外骨骼在醫療產業的應用越來越多,從物理治療到緊急服務。例如,總部位於德里的新興企業GenElek Technologies 提供機器人輔助系統,幫助患有中風、癱瘓、脊髓損傷 (SCI) 或其他神經系統疾病的人。外骨骼幫助殘障人士重新行走。它幫助他們變得獨立和自力更生,對他們的身心都有好處。上述這些進步預計將推動醫療保健市場的發展。
  • 印度康復委員會的一份報告顯示,印度每年有超過 15,000 人因脊髓損傷或中風而失去行走能力,這意味著每年每百萬人中有 15 名新感染者。當地公司提供外戴機器人和增強人類邊緣系統能力的外骨骼支撐系統。
  • 此外,市場上的許多參與者都在不斷努力創新其產品,並獲得醫療保健行業人士的必要核准。例如,為下肢殘障人士提供機器人醫療設備的製造商ReWalk Robotics宣布,美國食品藥物管理局已批准該公司向美國康復中心出售其ReStore軟外裝系統。
  • 此外,一些規模較小的公司正在興起。例如,日本的 Archelis Inc. 展示了其 ArchelisFX 外骨骼,該外骨骼源自日語,意為「方便行走的椅子」。該設備的設計考慮了多種場景,包括背痛或最近接受手術的人。該公司表示,可以以約 5,000 美元的價格租用或購買。
  • 2021年1月,總部位於加州的外骨骼技術創新者suitX宣布推出其新型穿戴式外骨骼ShieldX。專為需要穿著厚防輻射圍裙的醫護人員而設計。 ShieldX將沉重的防輻射圍裙對使用者肩膀和脊椎的重量減輕了100%。 ShieldX 旨在減少與這些重型圍裙相關的頸部和背部傷害,這些傷害會縮短職業生涯並限制非工作活動。

亞太地區預計將佔據最大市場佔有率

  • 亞太地區是穿戴式機器人技術研發的領導者。尤其是韓國和日本,在研發方面處於市場領先地位。例如,2021年4月,韓國機械材料研究院的調查團隊開發了穿戴式機器人技術,這是一種西裝形狀的穿戴式設備,可用於從送貨到建築工作等各種物理任務。附著在手臂和大腿等身體部位以支撐肌肉。
  • 韓國一直是機器人和自動化技術的製造中心。注重研發和政府在創新技術上的支出是該國穿戴式機器人技術進步的關鍵因素。該國的私營部門也在積極擴大與穿戴式機器人和外骨骼相關的技術和應用範圍。
  • 例如,三星電子於2021年6月宣布,將於年終將用於醫療保健的穿戴式機器人商業化。這家韓國科技巨頭正在進入機器人領域,將其作為其主要成長動力之一。該公司表示,計劃推出一款穿戴式機器人,可以幫助站立、行走或跑步有困難的用戶,也可以用作健身設備。這款穿戴式機器人的價格預計在500萬韓元至1,000萬韓元之間,但該公司可能會降低價格,使其更實惠。
  • 穿戴式機器人和外骨骼市場的參與者正在增加在亞太地區的投資。例如,2021年4月,總部位於香港的外骨骼市場產業領導者Ekso Bionics宣布與澳洲皇家復健中心合作,進一步擴大其機器人外骨骼在亞太地區的使用。
  • 該地區的軍隊也在開發軍用外骨骼機器人。例如,2021年10月,台灣推出了第一代電池供電的外骨骼套裝,可以提高士兵的身體耐力,並增加他們在各種軍事行動中的機動性。

穿戴式機器人及外骨骼產業概況

由於 Cyber​​dyne Inc.、ReWalk Robotics Inc. 和 Ekso Bionics Holdings Inc. 等主要參與者的存在,穿戴式機器人和外骨骼市場本質上競爭激烈。此外,市場潛力導致許多Start-Ups投資該市場,加劇了競爭。許多公司透過推出新產品、擴大業務或策略併購來擴大市場佔有率。

  • 2021年7月,Cyber​​dyne Co., Ltd.與J-Workout Co., Ltd.(東京江東區,總裁兼首席執行官:Takunori Isa,以下簡稱“J-Workout”)建立了業務,並從 2021 年 8 月起,我們將提供以下新服務。 Neuro HALFIT 是一種透過使用穿戴式半機械人 HAL 活化大腦神經系統活動循環來促進運動功能下降患者功能改善的服務。
  • 2021 年 3 月 - Ekso Bionics 宣布與美國的物理治療師建立合作關係,向醫生宣傳 EksoNR 外骨骼的臨床益處。此次合作將有助於提高醫生和其他復健治療師對 Ekso Bionics 技術的認知,並教導他們如何成功地將機器人技術融入復健計畫中。

其他福利

  • Excel 格式的市場預測 (ME) 表
  • 3 個月分析師支持

目錄

第1章 簡介

  • 研究假設和市場定義
  • 調查範圍

第2章調查方法

第3章執行摘要

第4章市場洞察

  • 市場概況
  • 產業吸引力-波特五力分析
    • 新進入者的威脅
    • 買方議價能力
    • 供應商的議價能力
    • 替代威脅
    • 競爭公司之間敵對的強度
  • 評估感染疾病-19 對產業的影響

第5章市場動態

  • 市場促進因素
    • 醫療保健產業對機器人復健的需求不斷增加
    • 加大外骨骼技術研發投入
  • 市場限制因素
    • 設備成本高

第6章市場區隔

  • 按類型
    • 動力外骨骼
    • 被動外骨骼
  • 按最終用戶產業
    • 衛生保健
    • 軍事和國防
    • 產業
    • 其他最終用戶產業
  • 按地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 世界其他地區

第7章 競爭形勢

  • 公司簡介
    • Cyberdyne Inc.
    • ReWalk Robotics Inc.
    • Ekso Bionics Holdings Inc.
    • Sarcos Corporation
    • Honda Motor Co. Ltd.
    • Hocoma AG(DIH International Ltd.)
    • Lockheed Martin Corporation
    • Technaid. SL
    • Skelex
    • ATOUN Inc.

第8章投資分析

第9章市場的未來

簡介目錄
Product Code: 67219

The Wearable Robots and Exoskeletons Market size is estimated at USD 2.55 billion in 2024, and is expected to reach USD 10.25 billion by 2029, growing at a CAGR of 32.05% during the forecast period (2024-2029).

Wearable Robots and Exoskeletons - Market

Due to the emergence of the COVID-19 pandemic, the previously put lockdown measures across various regions significantly brought the robotic suppliers to a complete standstill for a short period. However, on the other hand, the pandemic has also created productive industry opportunities for the products and service providers to increase their presence in the market by primarily focusing on and addressing real clinical challenges in collaboration with clinicians and industry partners and in response to the evolving patients' needs.

Key Highlights

  • The wearable robots or exoskeletons are in their nascent stage of development and continuously evolving to exhibit maximum adoption in various industries, like healthcare, industrial, military, and defense, as these wearable exoskeletons assist personal mobility and can be worn on the human body and control and assists the movements of the person.
  • In the healthcare sector, exoskeletons are helping patients' recovery by assisting and encouraging upright walking and relearning lost functions for stroke patients and people who are paralyzed. According to a study by Maxon Motor AG, the company estimated that approximately 185 million people use a wheelchair daily worldwide.
  • For instance, Ekso GT is an exoskeleton by Esko Bionics, which is a wearable exoskeleton engineered as a comprehensive gait therapy tool and provides an unparalleled rehabilitation experience for patients and therapists. Additionally, due to technological developments in technology, a paralyzed man started walking using a mind-controlled exoskeleton in France.
  • Various companies in the industry have already tested exoskeletons for their manufacturing capabilities and are ready to deploy them, which is likely to augment the market in the future further. For instance, automobile manufacturer, Ford, planned to deploy exoskeletons in fifteen assembly plants worldwide and adopted the EksoVest. This exoskeleton elevates and supports the arms of workers performing repeated overhead tasks. The adoption of EksoVests reduced workplace injuries by 83% during the trial period.
  • There is also an increasing demand for exoskeletons to assist in personal mobility. An increasing number of patients with body movement disorders, such as Parkinson's disease, strokes, etc., are the prime factors accelerating the exoskeleton demand, as these diseases limit voluntary body movements and create problems in daily routine activities. For instance, according to the Parkinson's Foundation estimates, the number of people in the United States with Parkinson's disease may be around 930,000 in 2020, and it is expected to reach 1,200,000 by 2030.

Wearable Robots & Exoskeletons Market Trends

Healthcare is Expected to Hold a Significant Share

  • Exoskeletons have increasing applications in medical industries ranging from physiotherapy to emergency services. For example, GenElek Technologies, a Delhi-based startup, provides a robotic support system that aids people suffering from stroke, paralysis, spinal cord injury (SCI), or other neurological conditions. The exoskeleton assists disabled people in walking again. It will help them become self-reliant and independent, which will benefit them physically and mentally. These advancements mentioned above are expected to drive the healthcare market.
  • According to a report of the Rehabilitation Council of India, every year, more than 15,000 people lose their ability to walk either due to a spinal injury or stroke in India, which translates to 15 new cases per million every year, which provides an opportunity for local companies to provide an externally worn robotic and exoskeleton support system that enhances a human's limbic capabilities.
  • Further, many players in the market are constantly trying to innovate products for people in the Healthcare industry and get the necessary approval. For instance, ReWalk Robotics, a manufacturer of robotic medical devices for individuals with lower limb disabilities, announced that the US Food and Drug Administration had cleared its ReStore soft exo-suit system for sale to rehabilitation centers across the United States.
  • Moreover, some smaller companies have also emerged. For instance, Japan-based Archelis Inc. showcased the ArchelisFX exoskeleton, which derives from the Japanese word for "walkable chair." The device is designed for several scenarios, including back pain and recently undergoing surgery. The company said it would be available to rent or buy for around USD 5,000.
  • In January 2021, suitX, a California-based innovator in exoskeleton technologies, announced the launch of a novel wearable exoskeleton, shieldX. It is made for the healthcare personnel required to wear heavy anti-radiation aprons. ShieldX removes 100% of the weight of a heavy anti-radiation apron from the user's shoulders and spine. ShieldX aims to reduce neck and back injuries linked to these heavy aprons shortening careers and limiting activities outside of work.

Asia Pacific is Expected to Account for the Largest Market Share

  • Asia-Pacific is the leader in the R&D of wearable robot technology. South Korea and Japan are specifically leading in the R&D of the market. For instance, in April 2021, a South Korean research team from the Korea Institute of Machinery and Materials developed a wearable robot technology, a suit-type wearable device, that can be used for a variety of physical tasks from delivery to construction work. It can be attached to the arm, thigh, and other body areas for supporting muscles.
  • South Korea has always been the hub for the manufacture of robotics and automation technologies. The focus on R&D and government expenditure on innovative technologies were significant factors for the advancement of wearable robotics in the country. The private sector of the country is also actively expanding its technologies and applications range related to wearable robots and exoskeletons.
  • For instance, in June 2021, Samsung Electronics Co. announced to commercialize of a wearable robot for healthcare by the end of 2021. This South Korean tech giant is delving into the robotics sector as one of its major growth drivers. According to the company, it has plans to introduce a wearable robot that helps users that have trouble standing up, walking, or running and can also be used as a fitness device. This wearable robot is expected to be priced between KRW 5 million and KRW 10 million, but the company may bring the price down to make it more affordable.
  • Wearable robots and exoskeleton market players are increasingly investing in the Asia-Pacific region. For instance, in April 2021, Ekso Bionics, an industry leader in the exoskeleton market with a presence in Hong Kong, announced a partnership with Royal Rehab in Australia, further expanding the use of the company's robotic exoskeleton across Asia-Pacific.
  • Militaries in the region are also developing exoskeleton robots for their troops. For instance, in October 2021, Taiwan launched the first generation of a battery-powered exoskeleton suit that can improve the physical endurance of soldiers and increase mobility in various military operations.

Wearable Robots & Exoskeletons Industry Overview

The Wearable Robots and Exoskeletons Market is competitive in nature because of the presence of major players like Cyberdyne Inc., ReWalk Robotics Inc., and Ekso Bionics Holdings Inc., among others. Further, the market potential is also attracting many startups investing in the market, thus, intensifying the competition. Many companies increase their market presence by introducing new products, expanding their operations, or entering into strategic mergers and acquisitions.

  • July 2021 - Cyberdyne Inc has formed a business alliance with J-Workout Inc. (Koto-Ku, Tokyo, Japan, President: Takunori Isa, "J-Workout") to provide a new service stated below from August 2021. The Group provides Neuro HALFIT as a service to promote the functional improvement of people with reduced motor functions by activating the activity loop of the brain's nervous system with Wearable Cyborg HAL.
  • March 2021 - Ekso Bionics announced a partnership with the US Physiatry to educate physicians on the clinical benefits of an EksoNR exoskeleton. The partnership will help raise awareness of Ekso Bionics technology among physicians and other rehabilitation therapists and teach them how to integrate robotics into rehabilitation programs successfully.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

  • 4.1 Market Overview
  • 4.2 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.2.1 Threat of New Entrants
    • 4.2.2 Bargaining Power of Buyers
    • 4.2.3 Bargaining Power of Suppliers
    • 4.2.4 Threat of Substitute
    • 4.2.5 Intensity of Competitive Rivalry
  • 4.3 Assessment of the COVID-19 Impact on the Industry

5 MARKET DYNAMICS

  • 5.1 Market Drivers
    • 5.1.1 Increasing Demand for Robotic Rehabilitation in Healthcare Industry
    • 5.1.2 Growing Investment in the Development of the Exoskeleton Technology
  • 5.2 Market Restraints
    • 5.2.1 High Cost of the Equipment

6 MARKET SEGMENTATION

  • 6.1 By Type
    • 6.1.1 Powered Exoskeletons
    • 6.1.2 Passive Exoskeletons
  • 6.2 By End-user Industry
    • 6.2.1 Healthcare
    • 6.2.2 Military and Defense
    • 6.2.3 Industrial
    • 6.2.4 Other End-user Industries
  • 6.3 By Geography
    • 6.3.1 North America
    • 6.3.2 Europe
    • 6.3.3 Asia Pacific
    • 6.3.4 Rest of the World

7 COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Cyberdyne Inc.
    • 7.1.2 ReWalk Robotics Inc.
    • 7.1.3 Ekso Bionics Holdings Inc.
    • 7.1.4 Sarcos Corporation
    • 7.1.5 Honda Motor Co. Ltd.
    • 7.1.6 Hocoma AG (DIH International Ltd.)
    • 7.1.7 Lockheed Martin Corporation
    • 7.1.8 Technaid. S.L.
    • 7.1.9 Skelex
    • 7.1.10 ATOUN Inc.

8 INVESTMENT ANALYSIS

9 FUTURE OF THE MARKET